Elite Pharmaceuticals reappoints Carter Ward as CFO effective Sept 5, 2023

ELITE PHARMACEUTICALS INC /NV/

Carter Ward reappointed CFO, secretary, treasurer; previously served from July 2009 to May 2021.
Base salary $275,000; guaranteed annual bonus 20% of base; performance bonus up to 30%.
Granted options to purchase 3,000,000 shares at closing price on effective date.
Severance: 2 months salary per year of service (max 12 months) if terminated without cause or for good reason.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Carter J. Ward

chief financial officer, secretary, and treasurer

ELTP · ELITE PHARMACEUTICALS INC /NV/

Effective: 2023-09-05
Filed: September 7, 2023, 7:59 PM ET

On September 5, 2023 (the “Effective Date”), Carter J. Ward was appointed as the Company’s chief financial officer, secretary, and treasurer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carter J. Ward was appointed as chief financial officer, secretary, and treasurer at ELITE PHARMACEUTICALS INC /NV/.

Action: appointed
Role: chief financial officer, secretary, and treasurer

Exact text from the filing

On September 5, 2023 (the “Effective Date”), Carter J. Ward was appointed as the Company’s chief financial officer, secretary, and treasurer.

View on SEC.gov

ELITE PHARMACEUTICALS INC /NV/ filing history →

Source: SEC EDGAR

accession 0001493152-23-031972

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.